why choose us

First received: May 30, 2023

Clinical Trial: A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Solid Tumors Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1, First-in-Human, Dose-Escalation and Expansion Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Brief Summary: The goal of this clinical trial is to study the safety and tolerability in all advanced solid tumors, including advanced urothelial carcinoma.The main question[s] it aims to answer are:Is FX-909 safe and tolerableWhat is the right dose level for patientsParticipants will be asked to take FX-909 daily , in tablet form and record any outcomes from taking the drug.Participants will also be asked to return for multiple site visits for various blood tests and to collect blood and tumor samples as well as have regular…

Read more